Cargando…

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers

Non-small cell lung cancer (NSCLC) consists of several subtypes, including adenocarcinoma, squamous cell lung cancer, large cell lung cancer, and other rarer types. Platinum-based regimens are currently the standard for treatment of advanced NSCLC. Nedaplatin is reportedly associated with a high res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yijun, Liu, Qian, Wu, Kongju, Chu, Qian, Chen, Yuan, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617508/ https://www.ncbi.nlm.nih.gov/pubmed/28977948 http://dx.doi.org/10.18632/oncotarget.17499

Ejemplares similares

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma
por: Zhang, Feng, et al.
Publicado: (2017)

Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma
por: Ge, You, et al.
Publicado: (2019)

Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis
por: Kim, Bo Hae, et al.
Publicado: (2018)

Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2017)

Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis
por: Guo, Wei, et al.
Publicado: (2017)

Polymorphisms in four microRNAs and risk of oral squamous cell cancer: a meta-analysis
por: Zeng, Junfeng, et al.
Publicado: (2018)

Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: Jiang, Kai-Yuan, et al.
Publicado: (2021)

Association Between Mitochondrial DNA Copy Number and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Dose-Response Meta-Analysis
por: Zhu, Zhu, et al.
Publicado: (2021)

Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)

Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis
por: Sun, Guorui, et al.
Publicado: (2017)

Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis
por: Surov, Alexey, et al.
Publicado: (2021)

Efficacy and safety of chimeric antigen receptor-T cells in the treatment of B cell lymphoma: a systematic review and meta-analysis
por: Zheng, Xiao-Hong, et al.
Publicado: (2020)

Efficacy and safety of cyclosporine-based regimens for primary immune thrombocytopenia: a systematic review and meta-analysis
por: Li, Xiaojing, et al.
Publicado: (2023)

Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis
por: Ye, Lu, et al.
Publicado: (2020)

Cyclooxygenase-2–1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls
por: Deng, Dong-Lai, et al.
Publicado: (2015)

Expression of the long non-coding RNA HOTAIR as a prognostic factor in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
por: Troiano, Giuseppe, et al.
Publicado: (2017)

Systematic review and meta-analysis of the efficacy of serum neuron-specific enolase for early small cell lung cancer screening
por: Huang, Lang, et al.
Publicado: (2017)

Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2017)

The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis
por: Han, Shiqian, et al.
Publicado: (2017)

Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis
por: Xu, Linchun, et al.
Publicado: (2023)

Cumulative meta-analysis and trial sequential analysis of correlation between hOGG1 Ser326Cys polymorphism and the risk of head and neck squamous cell carcinoma
por: Yan, Yan, et al.
Publicado: (2018)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
por: Jin, Zhe, et al.
Publicado: (2020)

Comparative efficacy and safety of antibody induction therapy for the treatment of kidney: a network meta-analysis
por: Shao, Mingjie, et al.
Publicado: (2017)

Assessment of the safety and efficacy of combination chemotherapy and PD-1/PD-L1 inhibitor treatment of breast cancer: A meta-analysis
por: Qian, Da, et al.
Publicado: (2023)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis
por: Szilágyi, Ágnes Lilla, et al.
Publicado: (2018)

Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis
por: Zhao, Huawei, et al.
Publicado: (2022)

rs833061 and rs699947 on Promoter Gene of Vascular Endothelial Growth Factor (VEGF) and Associated Lung Cancer Susceptibility and Survival: A Meta-Analysis
por: Tu, Junwei, et al.
Publicado: (2014)

Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer
por: Li, Fei, et al.
Publicado: (2017)

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023)

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Manjunatha, T A, et al.
Publicado: (2021)

Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
por: Whittle, Emma, et al.
Publicado: (2019)

Efficacy and Safety of “On-Demand” Dapoxetine in Treatment of Patients with Premature Ejaculation: A Meta-Analysis
por: Du, Yuefeng, et al.
Publicado: (2019)

Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy
por: Wu, Di, et al.
Publicado: (2017)

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
por: Soo, Ross A., et al.
Publicado: (2018)

Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis
por: Lyu, Wen-Wen, et al.
Publicado: (2016)

Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis
por: Wen, Yaokai, et al.
Publicado: (2022)

Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
por: Omae, Kenji, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_voa7m7tqje59u4r2jibcd6ds8m